Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression

• Ivan Sloma,
• Philip Beer,
• Christophe Desterke,
• Elizabeth Bulaeva,
• Misha Bilenky,
• Annaïck Carles,
• Michelle Moksa,
• Kamini Raghuram,
• Cedric Brimacombe,
• Karen Lambie,
• Ali G. Turhan,
• Orianne Wagner-Ballon,
• Philippe Gaulard,
• Keith Humphries,
• Martin Hirst,
• Connie J. Eaves

Affiliations

Ivan Sloma

Univ Paris Est Creteil, INSERM, IMRB, AP-HP, Hopital Universitaire Henri Mondor, Creteil, France;

Philip Beer

Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;

Christophe Desterke

Universite Paris-Sud, Faculte de Medecine Kremlin Bicetre, INSERM UMS33 Villejuif, France;

Elizabeth Bulaeva

Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;

Misha Bilenky

Canada Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada;

Annaïck Carles

Dept of Microbiology and Immunology, Michael Smith Laboratories, UBC, Vancouver, BC, Canada;

Michelle Moksa

Department of Microbiology and Immunology, Michael Smith Laboratories, UBC, Vancouver, BC, Canada;

Kamini Raghuram

Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;

Cedric Brimacombe

Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;

Karen Lambie

Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;

Ali G. Turhan

INSERM U935, Hopitaux Universitaires Paris-Sud, AP-HP, Kremlin Bicetre, France;

Orianne Wagner-Ballon

INSERM UMRS955, Hopital Universitaire Henri Mondor, AP-HP, UPEC, Creteil, France;

Philippe Gaulard

INSERM UMRS955, Hopital Universitaire Henri Mondor, AP-HP, UPEC, Creteil, France;

Keith Humphries

Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;

Martin Hirst

Canada Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada

Connie J. Eaves

Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;